is a privately owned biotechnology company developing gene based technology to treat genetic and acquired human diseases.
In September 2001, GeneCure LLC received a $280,000 research grant from National Institutes of Health, USA to develop a novel gene transfer vector for human gene therapy.
In September 1999, GeneCure LLC received a $300,000 research grant from National Institutes of Health, USA to test an animal model of potential AIDS vaccine.
In August 2000, GeneCure LLC received a $50,000 research partnership grant from Georgia Research Alliance, Atlanta, Georgia United States of America for developing an HIV vaccine.
GeneCure LLC was chosen as an emerging biotech company in May 2000 issue of Start-Up magazine.